4.3 Article

Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study

期刊

GYNECOLOGICAL ENDOCRINOLOGY
卷 38, 期 1, 页码 63-67

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/09513590.2021.1991909

关键词

Uterine fibroid; leiomyomas; myomas; vitamin D; green tea; epigallocatechin

向作者/读者索取更多资源

The simultaneous administration of Vitamin D and Epigallocatechin gallate has shown significant reduction in uterine fibroid size, particularly in patients with intramural type. There was a decrease in menstrual flow length after treatment, but no other significant changes were observed. Patients reported high satisfaction with the treatment.
Objective The beneficial effects of Vitamin D (VD) and Epigallocatechin gallate (EGCG), a polyphenol of green tea, on the growth of uterine fibroids (UF) were previously described in vitro and in vivo. We have decided to investigate their simultaneous administration in women with UFs in late reproductive life. Methods >40 years old n = 16 premenopausal women with intramural (IM) or subserosal (SS) UF of >= 3 cm or several UFs of different sizes, even smaller but with a total diameter >= 3 cm but <10 cm, without further concomitant organic causes of abnormal uterine bleeding, treated with EGCG 300 mg, Vitamin B6 10 mg and VD 50 mu g/day for 90 days. Women completed a diary on a daily basis to obtain information about bleeding and pelvic pain. Results We have observed a significant reduction in UF's mean size both at patient's (-17.8%, p = .03) and at single UF's level (-37.3%, p = .015). The effect was more evident in women with predominant IM (p = .016) in comparison to SS UFs. No significant changes were observed for uterine and ovarian volume and endometrial thickness during treatment. We reported a significant decrease in menstrual flow length of 0.9 day (p = .04) with no modification in cycle length, menstrual flow intensity and menstrual pain intensity. The satisfaction with treatment was in general very high, with no adverse effects reported. Conclusion The concomitant administration of VD and EGCG represents a promising treatment of UF in women of late reproductive life for which hormonal manipulation is not foreseen.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据